Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 736 AL 750

Molecular aspects of monoamine oxidase B

Ramsay RR.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Aug 1;69:81-9. doi: 10.1016/j.pnpbp.2016.02.005. Epub 2016 Feb 16.

Ultrasound treatment of neurological diseases--current and emerging applications

Leinenga G, Langton C, Nisbet R, Götz J.

Nat Rev Neurol. 2016 Mar;12(3):161-74. doi: 10.1038/nrneurol.2016.13. Epub 2016 Feb 19.

A review of current and novel levodopa formulations for the treatment of Parkinson's disease

Jimenez-Shahed J.

Ther Deliv. 2016;7(3):179-91. doi: 10.4155/tde.15.96.

Quadrupedal movement training improves markers of cognition and joint repositioning

Matthews MJ, Yusuf M, Doyle C, Thompson C.

Hum Mov Sci. 2016 Jun;47:70-80. doi: 10.1016/j.humov.2016.02.002. Epub 2016 Feb 17.

VAP, a Versatile Access Point for the Endoplasmic Reticulum: Review and analysis of FFAT-like motifs in the VAPome

Murphy SE, Levine TP.

Biochim Biophys Acta. 2016 Aug;1861(8 Pt B):952-961. doi: 10.1016/j.bbalip.2016.02.009. Epub 2016 Feb 17.

Comorbidity between neurological illness and psychiatric disorders

Hesdorffer DC.

CNS Spectr. 2016 Jun;21(3):230-8. doi: 10.1017/S1092852915000929. Epub 2016 Feb 22.

Novel Approaches to Optimization of Levodopa Therapy for Parkinson's Disease

Kianirad Y, Simuni T.

Curr Neurol Neurosci Rep. 2016 Apr;16(4):34. doi: 10.1007/s11910-016-0635-8.

Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases

Irwin MH, Moos WH, Faller DV, Steliou K, Pinkert CA.

Drug Dev Res. 2016 May;77(3):109-23. doi: 10.1002/ddr.21294. Epub 2016 Feb 21.

Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia

Moos WH, Maneta E, Pinkert CA, Irwin MH, Hoffman ME, Faller DV, Steliou K.

Drug Dev Res. 2016 Mar;77(2):53-72. doi: 10.1002/ddr.21295. Epub 2016 Feb 21.

There's Something Wrong with my MAM; the ER-Mitochondria Axis and Neurodegenerative Diseases

Paillusson S, Stoica R, Gomez-Suaga P, Lau DHW, Mueller S, Miller T, Miller CCJ.

Trends Neurosci. 2016 Mar;39(3):146-157. doi: 10.1016/j.tins.2016.01.008. Epub 2016 Feb 15.

Vocal tract characteristics in Parkinson's disease

Gillivan-Murphy P, Carding P, Miller N.

Curr Opin Otolaryngol Head Neck Surg. 2016 Jun;24(3):175-82. doi: 10.1097/MOO.0000000000000252.

Factors Related to Social Support in Neurological and Mental Disorders

Kamenov K, Cabello M, Caballero FF, Cieza A, Sabariego C, Raggi A, Anczewska M, Pitkänen T, Ayuso-Mateos JL.

PLoS One. 2016 Feb 22;11(2):e0149356. doi: 10.1371/journal.pone.0149356. eCollection 2016.

Changes in Olfactory Bulb Volume in Parkinson's Disease: A Systematic Review and Meta-Analysis

Li J, Gu CZ, Su JB, Zhu LH, Zhou Y, Huang HY, Liu CF.

PLoS One. 2016 Feb 22;11(2):e0149286. doi: 10.1371/journal.pone.0149286. eCollection 2016.

Interplay of endoplasmic reticulum stress and autophagy in neurodegenerative disorders

Cai Y, Arikkath J, Yang L, Guo ML, Periyasamy P, Buch S.

Autophagy. 2016;12(2):225-44. doi: 10.1080/15548627.2015.1121360.

Striatal Plasticity in L-DOPA- and Graft-Induced Dyskinesia; The Common Link?

Rylander Ottosson D, Lane E.

Front Cell Neurosci. 2016 Feb 8;10:16. doi: 10.3389/fncel.2016.00016. eCollection 2016.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias